Express Scripts Announces New Recommendations Tackling High Drug Prices
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Formulary Update Positive for Mylan (MYL) - Evercore ISI
August 7, 2018 10:05 AM EDTExpress Scripts' (NASDAQ: ESRX) formulary update today is positive for Mylan's (NYSE: MYL) HIV drug, Evercore ISI analsyt Umer Raffat notes.
"Today, ESRX issued a formulary update where they are now replacing Atripla with SYMFI.... More
